Literature DB >> 25367851

Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.

Li Li Lin1, Wei Wang, ZhaoYang Hu, Li Wen Wang, Jing Chang, HanGuang Qian.   

Abstract

Primary hepatocellular carcinoma (HCC) is the most common form of liver cancer and is one of the most common malignancies worldwide. Tumor suppressor gene silencing through DNA methylation contributes to cancer formation. The ten-eleven translocations (TET) family of α-ketogluta-rate-dependent dioxygenases catalyzes the sequential oxidation of 5-methylcytosine to 5-hydroxymethyl-cytosine, 5-formylcytosine and 5-carboxylcytosine, leading to eventual DNA demethylation. MicroRNAs are an abundant class of 17-25 nucleotides small noncoding RNAs, identified as important regulators of many diverse biological processes. In this study, we showed that TET1 expression was obviously reduced in the majority of examined HCC tissues. And we further investigated the expression and functional involvement of TET1 in proliferation, migration and invasion, and determined that TET1 may function as a tumor suppressor. MiR-29b was proved to inhibit metastasis through the targeting of TET1, indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression. Thus, we elucidated the roles of feedback of miR-29-TET1 downregulation in HCC development and suggested a potential target in identification of the prognosis and application of cancer therapy for HCC patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25367851     DOI: 10.1007/s12032-014-0291-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  36 in total

1.  Dnmt3L and the establishment of maternal genomic imprints.

Authors:  D Bourc'his; G L Xu; C S Lin; B Bollman; T H Bestor
Journal:  Science       Date:  2001-11-22       Impact factor: 47.728

Review 2.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

Review 3.  Linking DNA methylation and histone modification: patterns and paradigms.

Authors:  Howard Cedar; Yehudit Bergman
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

4.  MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

Authors:  Teng Xu; Ying Zhu; Yujuan Xiong; Yi-Yuan Ge; Jing-Ping Yun; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

5.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

Authors:  Ramiro Garzon; Shujun Liu; Muller Fabbri; Zhongfa Liu; Catherine E A Heaphy; Elisa Callegari; Sebastian Schwind; Jiuxia Pang; Jianhua Yu; Natarajan Muthusamy; Violaine Havelange; Stefano Volinia; William Blum; Laura J Rush; Danilo Perrotti; Michael Andreeff; Clara D Bloomfield; John C Byrd; Kenneth Chan; Lai-Chu Wu; Carlo M Croce; Guido Marcucci
Journal:  Blood       Date:  2009-02-11       Impact factor: 22.113

Review 6.  Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps.

Authors:  Augusto Villanueva; Sara Toffanin; Josep M Llovet
Journal:  Curr Opin Oncol       Date:  2008-07       Impact factor: 3.645

7.  Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.

Authors:  Laura Gramantieri; Manuela Ferracin; Francesca Fornari; Angelo Veronese; Silvia Sabbioni; Chang-Gong Liu; George A Calin; Catia Giovannini; Eros Ferrazzi; Gian Luca Grazi; Carlo M Croce; Luigi Bolondi; Massimo Negrini
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

8.  NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.

Authors:  Huating Wang; Ramiro Garzon; Hao Sun; Katherine J Ladner; Ravi Singh; Jason Dahlman; Alfred Cheng; Brett M Hall; Stephen J Qualman; Dawn S Chandler; Carlo M Croce; Denis C Guttridge
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

9.  Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Authors:  Jinmai Jiang; Yuriy Gusev; Ileana Aderca; Teresa A Mettler; David M Nagorney; Daniel J Brackett; Lewis R Roberts; Thomas D Schmittgen
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

10.  Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes.

Authors:  Chiara Braconi; Nicola Valeri; Pierluigi Gasparini; Nianyuan Huang; Cristian Taccioli; Gerard Nuovo; Tetsuro Suzuki; Carlo Maria Croce; Tushar Patel
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

View more
  13 in total

Review 1.  Epigenetic markers in melanoma.

Authors:  Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Melanoma Manag       Date:  2015-11-24

2.  Suppressive role of microRNA-29 in hepatocellular carcinoma via targeting IGF2BP1.

Authors:  Jianyi Yang; Xuejun Gong; Jing Yang; Linghua Ouyang; Rou Xiao; Xing You; Yanlan Ouyang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b.

Authors:  Wei Wang; Mei Wang; Jing Xu; Fei Long; Xianbao Zhan
Journal:  Cancer Cell Int       Date:  2020-07-24       Impact factor: 5.722

4.  MicroRNA-29 family inhibits rhabdomyosarcoma formation and progression by regulating GEFT function.

Authors:  Yang Wang; Liang Zhang; Yuweng Pang; Lingxie Song; Hao Shang; Zhenzhen Li; Qianqian Liu; Yangyang Zhang; Xiaomeng Wang; Qianru Li; Qiaochu Zhang; Chunxia Liu; Feng Li
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

5.  MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis.

Authors:  Qing Chen; Dan Yin; Yong Zhang; Lei Yu; Xue-Dong Li; Zheng-Jun Zhou; Shao-Lai Zhou; Dong-Mei Gao; Jie Hu; Cheng Jin; Zheng Wang; Ying-Hong Shi; Ya Cao; Jia Fan; Zhi Dai; Jian Zhou
Journal:  Cell Death Dis       Date:  2017-06-29       Impact factor: 8.469

6.  Effects of a single transient transfection of Ten-eleven translocation 1 catalytic domain on hepatocellular carcinoma.

Authors:  Yuying Liu; Hui Zhu; Zhenxue Zhang; Changchun Tu; Dongyuan Yao; Bin Wen; Ru Jiang; Xing Li; Pengfei Yi; Jiejie Zhan; Jiaping Hu; Jianwu Ding; Liping Jiang; Fanglin Zhang
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

Review 7.  Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.

Authors:  Mohammad Reza Karimzadeh; Peyman Pourdavoud; Naeim Ehtesham; Mohaddese Qadbeigi; Masood Movahedi Asl; Behrang Alani; Meysam Mosallaei; Bahram Pakzad
Journal:  Cancer Gene Ther       Date:  2020-08-10       Impact factor: 5.987

Review 8.  New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Authors:  Erika Larrea; Carla Sole; Lorea Manterola; Ibai Goicoechea; María Armesto; María Arestin; María M Caffarel; Angela M Araujo; María Araiz; Marta Fernandez-Mercado; Charles H Lawrie
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

9.  miR-29 regulates Tet1 expression and contributes to early differentiation of mouse ESCs.

Authors:  Yanhua Cui; Ting Li; Dehua Yang; Song Li; Weidong Le
Journal:  Oncotarget       Date:  2016-10-04

10.  TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.

Authors:  Jiangxia Fan; Yan Zhang; Junhao Mu; Xiaoqian He; Bianfei Shao; Dishu Zhou; Weiyan Peng; Jun Tang; Yu Jiang; Guosheng Ren; Tingxiu Xiang
Journal:  Clin Epigenetics       Date:  2018-08-03       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.